Search research articles
Contact Us
Filters
Showing results (61-70 of 133) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2023
Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non-Small Cell Lung Cancer
Miguel Lopez de Rodas, Yvonne Wang, Gang Peng, et al.
Cancer Investigation
|
February 25, 2012
Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer
Jonathan W Riess, Aaron C Logan, Yelena Krupitskaya, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2025
Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT
Clemens Mingels, Mohammad H Madani, Fatma Sen, et al.
Immunopharmacology and Immunotoxicology
|
February 6, 2014
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients
Jonathan W Riess, Nupur Bhattacharya, Kim R M Blenman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 2, 2017
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database
Sukhmani K Padda, Xiaopan Yao, Alberto Antonicelli, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 5, 2012
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy
Millie Das, Jonathan W Riess, Paul Frankel, et al.
JTO Clinical and Research Reports
|
November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy
Jacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
JTO Clinical and Research Reports
|
June 9, 2025
A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations
Jonathan W Riess, Matthew S Lara, Guillaume Luxardi, et al.
JCO Precision Oncology
|
May 26, 2021
Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer
Caroline E McCoach, Aiming Yu, David R Gandara, et al.
Cancer
|
May 5, 2020
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases
Philip C Mack, Kimberly C Banks, Carin R Espenschied, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 133) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 21, 2023
Objective Analysis and Clinical Significance of the Spatial Tumor-Infiltrating Lymphocyte Patterns in Non-Small Cell Lung Cancer
Miguel Lopez de Rodas, Yvonne Wang, Gang Peng, et al.
Cancer Investigation
|
February 25, 2012
Maintenance bevacizumab is associated with increased hemoglobin in patients with advanced, nonsquamous, non-small cell lung cancer
Jonathan W Riess, Aaron C Logan, Yelena Krupitskaya, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 21, 2025
Diagnostic accuracy in NSCLC lymph node staging with Total-Body and conventional PET/CT
Clemens Mingels, Mohammad H Madani, Fatma Sen, et al.
Immunopharmacology and Immunotoxicology
|
February 6, 2014
Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung cancer patients
Jonathan W Riess, Nupur Bhattacharya, Kim R M Blenman, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 2, 2017
Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database
Sukhmani K Padda, Xiaopan Yao, Alberto Antonicelli, et al.
Lung Cancer (Amsterdam, Netherlands)
|
May 5, 2012
ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy
Millie Das, Jonathan W Riess, Paul Frankel, et al.
JTO Clinical and Research Reports
|
November 19, 2025
DLL3 Immunohistochemical Expression in Neuroendocrine-Transformed <i>EGFR</i>-Mutant Lung Cancer and Two Cases of Tarlatamab Therapy
Jacqueline V Aredo, Surbhi Singhal, Gerald J Berry, et al.
JTO Clinical and Research Reports
|
June 9, 2025
A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations
Jonathan W Riess, Matthew S Lara, Guillaume Luxardi, et al.
JCO Precision Oncology
|
May 26, 2021
Phase I/II Study of Capmatinib Plus Erlotinib in Patients With MET-Positive Non-Small-Cell Lung Cancer
Caroline E McCoach, Aiming Yu, David R Gandara, et al.
Cancer
|
May 5, 2020
Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases
Philip C Mack, Kimberly C Banks, Carin R Espenschied, et al.
Page
of 14